The Crucial Role of Awareness and Education in Promoting Effective Diabetes Self-Management and Reducing the Risk of Complications
Öz
Objective: Disease awareness is a pivotal factor in the management of illness. In chronic and progressive conditions, such as diabetes mellitus (DM), this awareness can be as effective as pharmacological interventions. This study aimed to assess how aware diabetic patients are of the complications of their disease.
Method: This cross-sectional survey included patients diagnosed with DM. A total of 14 survey questions, divided into 7 different categories, were directed at the patients. The singular questions evaluated the patients' awareness of the complications, while the associated-secondary questions aimed to inquire about the sources of their awareness.
Result: In this study, a survey was conducted with 300 diabetic patients, yielding a response rate of 90.2%. The mean age was 53 years. The level of awareness of complications was high among all patients (80.5%). The awareness level of ocular-related complications was the highest, while that of neuropathy was the lowest (50%). When patients were categorized by educational status, education increased awareness but decreased adherence to combined drug use. The patients' doctors were identified as the most significant source of support for raising awareness of complications. This support was further enhanced by the educational level.
Conclusion: High levels of awareness of complications related to diabetes, still being primarily provided by doctors, and improvement of patients' educational status, can lead to a decrease in the number of patients with a poor prognosis. Therefore, increasing awareness of diabetes-related complications and improving patients' educational status may positively impact reducing the incidence of poor prognosis among diabetes patients.
Anahtar Kelimeler
Destekleyen Kurum
None
Kaynakça
- 1. American Diabetes A. Standards of Medical Care in Diabetes-2021 Abridged for Primary Care Providers. Clin Diabetes. 2021;39(1):14-43.
- 2. International Diabetes Federation. IDF Diabetes Atlas, 9th ed. Brussels, Belgium: International Diabetes Federation, 2019. Available from: https://www.diabetesatlas.org/en/. Accessed on 02.05.2023.
- 3. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88-98.
- 4. Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185-200.
- 5. Abdulghani HM, Ahmed MM, Al-Rezqi AM, Althunayan SA, Mran AL, Alshaya AK, et al. Knowledge and awareness levels of diabetes mellitus risk factors among nondiabetic visitors of primary health care centers: a multicenter study. Eur Rev Med Pharmacol Sci. 2021;25(22):7066-77.
- 6. American Diabetes A. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15-S33.
- 7. International Diabetes Federation Guideline Development G. Guideline for management of postmeal glucose in diabetes. Diabetes Res Clin Pract. 2014;103(2):256-68.
- 8. Tsapas A, Avgerinos I, Karagiannis T, Malandris K, Manolopoulos A, Andreadis P, et al. Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Ann Intern Med. 2020;173(4):278-86.
- 9. Bujang MA, Omar ED, Baharum NA. A Review on Sample Size Determination for Cronbach's Alpha Test: A Simple Guide for Researchers. Malays J Med Sci. 2018;25(6):85-99.
- 10. American Diabetes A. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S85-S99.
- 11. Xu Y, Pan W, Liu H. Self-management practices of Chinese Americans with type 2 diabetes. Nurs Health Sci. 2010;12(2):228-34.
- 12. Ismailzade M, Nursen HAB, İnce Bilsev. Comparison of Negative Pressure Wound Therapy with Conventional Wound Dressing in Diabetic Foot Osteomyelitis. Mev Med Sci. 2021;1(1):16-20.
- 13. Dibeklioglu SE, Eklioglu BS, Atabek ME. Case Report of Covid 19 Presenting with Diabetic Ketoacidosis. Mev Med Sci. 2022;2(1):42-44. 14. Javed S, Hayat T, Menon L, Alam U, Malik RA. Diabetic peripheral neuropathy in people with type 2 diabetes: too little too late. Diabet Med. 2020;37(4):573-9. 15. Pitocco D, Spanu T, Di Leo M, Vitiello R, Rizzi A, Tartaglione L, et al. Diabetic foot infections: a comprehensive overview. Eur Rev Med Pharmacol Sci. 2019;23(2 Suppl):26-37.
Etkili Diyabet Özyönetiminin Teşvik Edilmesinde ve Komplikasyon Riskinin Azaltılmasında Farkındalık ve Eğitimin Önemli Rolü
Öz
Amaç: Hastalık farkındalığı, hastalık yönetiminde önemli bir faktördür. Diyabet gibi kronik progresif bir hastalıkta bu bilinç ilaçlar kadar etkilidir. bu çalışmada diyabetli hastaların hastalıklarının komplikasyonlarından ne kadar haberdar olduklarını ölçmeyi amaçladık.
Methot: Bu kesitsel anket çalışmasına diyabet tanısı olan hastalar dahil edilmiştir. hastalara 7 farklı kategoride toplamda 14 anket sorusu yöneltilmiştir. Tekil sorular komplikasyonlardan haberdarlıklarını değerlendirirken, ilişkili-ikincil sorular ise haberdarlık kaynaklarını sorgulamakta idiler.
Bulgu: 300 hastanın anketi tamamladığı çalışmada, cevap oranı %90.2 idi. Ortalama yaş 53 idi. Tüm hastaların bilinçlilik düzeyi oldukça yüksekti (%80.5). Görme ile ilgili komplikasyonlardaki bilinçlilik düzeyi en fazla iken nöropati ile ilgili olanlar en düşük düzeyde idi (%50). Hastalar eğitim durumlarına göre kategorize edildiklerinde, eğitim durumu farkındalığı artırırken, kombine ilaç kullanımı uyumunu azalttıyor gibiydi. Hastaların komplikasyon bilinçlenmelerinde en yüksek yardımcı kaynak takip eden doktorları idi. Eğitim durumu ile bu destek daha da artmakta idi.
Sonuç: Diyabete bağlı komplikasyonların bilinçlilik düzeylerinin yüksek olması, bu bilincin halen doktorlar tarafından en üst düzeyde sağlanması ve hastaların öğrenim durumlarının iyileştirilmesi ile kötü prognozla seyreden hasta sayısını azaltacaktır. Bu nedenle, diyabetle ilişkili komplikasyonlar konusunda farkındalığın arttırılması ve hastaların eğitim durumunun iyileştirilmesi, diyabet hastalarında kötü prognoz insidansını azaltmada olumlu etki yapabilir.
Anahtar Kelimeler
Kaynakça
- 1. American Diabetes A. Standards of Medical Care in Diabetes-2021 Abridged for Primary Care Providers. Clin Diabetes. 2021;39(1):14-43.
- 2. International Diabetes Federation. IDF Diabetes Atlas, 9th ed. Brussels, Belgium: International Diabetes Federation, 2019. Available from: https://www.diabetesatlas.org/en/. Accessed on 02.05.2023.
- 3. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88-98.
- 4. Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185-200.
- 5. Abdulghani HM, Ahmed MM, Al-Rezqi AM, Althunayan SA, Mran AL, Alshaya AK, et al. Knowledge and awareness levels of diabetes mellitus risk factors among nondiabetic visitors of primary health care centers: a multicenter study. Eur Rev Med Pharmacol Sci. 2021;25(22):7066-77.
- 6. American Diabetes A. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15-S33.
- 7. International Diabetes Federation Guideline Development G. Guideline for management of postmeal glucose in diabetes. Diabetes Res Clin Pract. 2014;103(2):256-68.
- 8. Tsapas A, Avgerinos I, Karagiannis T, Malandris K, Manolopoulos A, Andreadis P, et al. Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Ann Intern Med. 2020;173(4):278-86.
- 9. Bujang MA, Omar ED, Baharum NA. A Review on Sample Size Determination for Cronbach's Alpha Test: A Simple Guide for Researchers. Malays J Med Sci. 2018;25(6):85-99.
- 10. American Diabetes A. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S85-S99.
- 11. Xu Y, Pan W, Liu H. Self-management practices of Chinese Americans with type 2 diabetes. Nurs Health Sci. 2010;12(2):228-34.
- 12. Ismailzade M, Nursen HAB, İnce Bilsev. Comparison of Negative Pressure Wound Therapy with Conventional Wound Dressing in Diabetic Foot Osteomyelitis. Mev Med Sci. 2021;1(1):16-20.
- 13. Dibeklioglu SE, Eklioglu BS, Atabek ME. Case Report of Covid 19 Presenting with Diabetic Ketoacidosis. Mev Med Sci. 2022;2(1):42-44. 14. Javed S, Hayat T, Menon L, Alam U, Malik RA. Diabetic peripheral neuropathy in people with type 2 diabetes: too little too late. Diabet Med. 2020;37(4):573-9. 15. Pitocco D, Spanu T, Di Leo M, Vitiello R, Rizzi A, Tartaglione L, et al. Diabetic foot infections: a comprehensive overview. Eur Rev Med Pharmacol Sci. 2019;23(2 Suppl):26-37.
Ayrıntılar
| Birincil Dil | İngilizce |
|---|---|
| Konular | Sağlık Kurumları Yönetimi |
| Bölüm | Makaleler |
| Yazarlar | |
| Yayımlanma Tarihi | 20 Ekim 2023 |
| Kabul Tarihi | 15 Eylül 2023 |
| Yayımlandığı Sayı | Yıl 2023 Cilt: 15 Sayı: 3 |
